Cell Reports Medicine (May 2021)

Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome

  • Luke Y.C. Chen,
  • Catherine M. Biggs,
  • Shahin Jamal,
  • Sophie Stukas,
  • Cheryl L. Wellington,
  • Mypinder S. Sekhon

Journal volume & issue
Vol. 2, no. 5
p. 100269

Abstract

Read online

Summary: Data suggest that interleukin (IL)-6 blockade could reduce mortality in severe COVID-19, yet IL-6 is only modestly elevated in most patients. Chen et al. describe the role of soluble interleukin-6 receptor (sIL-6R) in IL-6 trans-signaling and how understanding the IL-6:sIL-6R axis might help define and treat COVID-19 cytokine storm syndrome.

Keywords